Literature DB >> 6405549

[Effect of different concentrations of various zinc complexes (picolinate, citrate, 8-hydroxyquinolate) in comparison with sulfate on zinc supply status in rats].

H P Roth, M Kirchgessner.   

Abstract

12 groups of 8 young male Sprague-Dawley rats received a semisynthetic casein-diet, whose zinc concentration (1.3 ppm) was adjusted to 5, 10 and 15 ppm by supplementation of various Zn complexes or salts like Zn citrate, Zn picolinate, Zn 8-hydroxyquinolate and Zn sulfate. After 24 days all animals were killed and examined on parameters of zinc supply status. The weight gain of the animals with 5 ppm dietary zinc was strongly reduced compared to groups with the higher dietary zinc content. The type of the supplemented Zn compound showed in no way an influence on the live-weight of the animals. The zinc concentration of the tissues, too, was only dependent on the level of the dietary zinc concentration and not on the type of supplemented zinc compound. The activity of the alkaline phosphatase in serum, a zinc metalloenzyme, was altogether reduced in the zinc-deficient animals with 5 ppm dietary zinc content, but showed a significant higher activity in the citrate and 8-hydroxyquinolate group than in the sulfate and picolinate group. Also the percent zinc-binding capacity of serum, a good indicator for estimating the zinc supply status of rats, showed a better zinc supply of the citrate group with 5 as well as 10 ppm dietary zinc, compared with the other groups on the same dietary zinc content. The serum zinc concentration of rats with 5 ppm as Zn citrate was more than twice higher than in animals given zinc as picolinate, 8-hydroxyquinolate or sulfate. The results indicate a better utilization of zinc chelated by citric acid than by picolinic acid, 8-hydroxyquinoline or as salt like sulfate. But the higher bioavailability of zinc in human milk should not only be attributed to the presence of citrate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405549     DOI: 10.1007/BF02020783

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  26 in total

1.  [Effect of zinc deficiency on glucose tolerance].

Authors:  H P Roth; U Schneider; M Kirchgessner
Journal:  Arch Tierernahr       Date:  1975-10

2.  Zinc and di-iodohydroxyquinoline therapy in acrodermatitis enteropathica.

Authors:  M J Jackson
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

3.  Picolinic acid as a zinc-binding ligand in human milk: an unconvincing case.

Authors:  L S Hurley; B Lönnerdal
Journal:  Pediatr Res       Date:  1981-02       Impact factor: 3.756

4.  Tryptophan, picolinic acid and zinc absorption: an unconvincing case.

Authors:  L S Hurley; B Lönnerdal
Journal:  J Nutr       Date:  1980-12       Impact factor: 4.798

5.  Zinc concentration of liver and kidneys from rat pups nursing dams fed supplemented zinc dipicolinate or zinc acetate.

Authors:  G W Evans; E C Johnson
Journal:  J Nutr       Date:  1980-10       Impact factor: 4.798

6.  Influence of various phosphates and other complexing agents on the availability of zinc for turkey poults.

Authors:  P Vohra; F H Kratzer
Journal:  J Nutr       Date:  1966-05       Impact factor: 4.798

7.  [Acrodermatitis enteropathica--a disturbance of zinc metabolism with zinc malabsorption (author's transl)].

Authors:  I Lombeck; H G Schnippering; K Kasperek; F Ritzl; H Kästner; L E Feinendegen; H J Bremer
Journal:  Z Kinderheilkd       Date:  1975-09-11

8.  Availability of zinc: loading tests with human milk, cow's milk, and infant formulas.

Authors:  C E Casey; P A Walravens; K M Hambidge
Journal:  Pediatrics       Date:  1981-09       Impact factor: 7.124

9.  Zinc absorption in cattle with a dietary picolinic acid supplement.

Authors:  T Flagstad
Journal:  J Nutr       Date:  1981-11       Impact factor: 4.798

10.  Tissue uptake of zinc in rats following the administration of zinc dipicolinate or zinc histidinate.

Authors:  W T Johnson; G W Evans
Journal:  J Nutr       Date:  1982-05       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.